Part Number : NDC00536-4395-01 | Manufacturer : Rugby Group Inc | ||
NSN : 6505-01-352-2389 (6505013522389) | |||
Item Name : Pancrelipase Tablets Usp | CAGE Code : 4V824 | ||
NIIN : 01-352-2389 (013522389) | |||
INC Code : 34464 | |||
NCB Code : 01 | Country : USA | ||
Alternate P/N: NDC00536439501 |
Thank you for taking an interest in part number NDC00536-4395-01, that of which is listed with the description Pancrelipase Tablets Usp; Manufactured by Rugby Group Inc and listed alongside the NSN 6505013522389, part number NDC00536-4395-01 is available for immediate purchase on our website. As such, to learn more about this offering while receiving a competitive quote for your comparisons, be sure to fill out and submit the RFQ form presented on this page. Within 15 minutes of us receiving and reviewing a completed form, a member of our staff will contact you to present a tailored solution for your comparisons.
Part Number : NDC00536-4395-01 | Manufacturer : Rugby Group Inc | ||
NSN Number : 6505-01-352-2389 (6505013522389) | |||
Item Name : Pancrelipase Tablets Usp | CAGE Code : 4V824 | ||
NIIN : 013522389 |
Thank you for taking an interest in part number NDC00536-4395-01, that of which is listed with the description Pancrelipase Tablets Usp; Manufactured by Rugby Group Inc and listed alongside the NSN 6505013522389, part number NDC00536-4395-01 is available for immediate purchase on our website. As such, to learn more about this offering while receiving a competitive quote for your comparisons, be sure to fill out and submit the RFQ form presented on this page. Within 15 minutes of us receiving and reviewing a completed form, a member of our staff will contact you to present a tailored solution for your comparisons.
NSN | FSC | NIIN | CLS | Hazmat | DEMIL | Cancelled NSN |
---|---|---|---|---|---|---|
6505-01-352-2389 Item PartTypeName: PANCRELIPASE TABLETS | 6505 | 013522389 | K | P | ||
CIIC | HCC | ESD | PMIC | Criticality | ENAC | |
U | A | |||||
Part Number | ISC | RNVC | RNCC | HCC | MSDS | SADC |
NDC00091-3525-01 | 5 | 2 | 3 |
MRC | Criteria | Characteristic |
---|---|---|
MDES | MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 30000.000 USP UNITS AMYLASE ACTIVE INGREDIENT AND 8000.000 USP UNITS LIPASE ACTIVE INGREDIENT AND 30000.000 USP UNITS PROTEASE ACTIVE INGREDIENT |
CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 100.000 TABLETS |
CQCT | PRIMARY CONTAINER TYPE | BOTTLE |
CSGS | ADMINISTRATION | ORAL |
We hope that you will visit us again the next time you need board-level components, aviation and aerospace parts, and more. Allow us to serve as your strategic purchasing partner.
Request for Quote